Dr. Comanita specializes in strategic marketing for the fine and specialty chemicals industry. He is also the managing partner in MarketChemica & Assoc.
- Bogdan started from scratch global and regional markets including VIRIDISOL®, the fastest growing carbon neutral solvent in pharma; he authored EU, US and World patents and peer reviewed articles in fields as diverse as pharmaceuticals, nanotechnology and polymers.
- Bogdan consults for leaders in cutting edge verticals such as mRNA vaccines, EV batteries and CVD for photovoltaics and computer chips.
- Recent M&A: Australian bank $60 MM investment in US rPET plant, Canadian pension fund Series C $125 MM investment in US platform technology company and $10 MM CDMO sell deal in Eastern Eu.
- Dr. Comanita sits on the Editorial Board of Chemistry Today, the leading trade publication in fine and specialty chemicals.
- Bogdan has a PhD Chemistry from Ottawa University, a MBA from Western University and a Ms. Chem. Eng from Asachi Polytechnic Institute
- Dr. Gommers Peter has a PhD in Biotechnology/Chemical Engineering from Technische Universiteit Delft and an MBA from INSEAD. He has worked in the industry over thirty (30) years.
- Based in the Netherlands, Peter's global work experience covers companies like Shell, DSM, AkzoNobel and Nouryon, as well as McKinsey & Co.
- Peter works with investment banks, venture capital and private equity houses on acquisitions, divestitures, carve outs and joint ventures and he was instrumental in Nouryon's multibillion dollar carve out from AkzoNobel and post-transaction integration.
- Dr. Gommers operational experience goes commodity, specialty and consumer oriented chemical markets for example Biotechnology, Inorganic Chemical, Catalysis and Adhesives.
- Peter is supporting clients with business strategies (for single and portfolois of businesses), creating growth (both organic and M&A), realizing organization change, Commercial Excellence (traditional and digital) and integrating Sustainability into vision, strategy and everyday business.
- Mr. Xavier Jeanjean has 30 years experience with industry leaders such as Huls, Chemetall, Rohner, Isochem and Seqens.
- Xavier was in charge with the full breadth of operational challenges from R&D pipeline management, to developing purchasing and marketing strategy at the global and regional scale.
- He focused much of his recent work on strategic sourcing and supply risk management for CDMO in the chemical space.
- Xavier was involved with various strategic M&A's transactions and divestitures; he currently advises private equity and investment banks and venture funds both on the buy and on the sell side.
- Xavier has a DEA in chemical engineering from Université de Technologie de Compiègne, a masters ICG in management from IFG and a degree in chemical engineering from "École supérieure de Chimie organique et minérale".
- Dr. Newman has a PhD in chemical engineering & chemical technology from Imperial College of Science, Tehcnology & Medecine, London, UK, and a diploma in cosmetic science from the London College of Fashion.
- He spent 17 years in the chemical industry leading multi-functional teams for the identification and commercialization of new chemicals, followed by 19 years working on the development & commercialization of new consumer products.
- Ronald consults fro companies in; consumer products; CBD and specialty product formulation chemistry, quality assurance, risk assessment, process start-up, complex chemistry troubleshooting, supply chain intelligence.
- Ron advises buy side institutional investors in terms of their risk exposure to intellectual property, quality assurance, scale-up and manufacturing aspects.
- He has been a frequent contributor to "Household & Personal Care Today" writing about promising consumer product applications of renewable materials. Ronald has his own laboratory where he creates custom formulations for a diverse range of applications.